SCHEMBL466357

SCHEMBL466357

CC1=CCC[CH]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4948546 0.82
SCHEMBL895220 0.75
SCHEMBL8758 0.75
SCHEMBL11792566 0.71
SCHEMBL2409777 0.71
SCHEMBL767081 0.71
SCHEMBL1269421 0.69 PTPN1 (0.48)
SCHEMBL1269417 0.69 PTPN1 (0.48)
SCHEMBL797340 0.68
Ethylene SCHEMBL6511490 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091945-B1 NOVEL INHIBITORS OF GLUTAMINYL CYCLASE PROBIODRUG AG (DE) 2014-01-15 EP claimed
CN-103374130-A Aromatic polyimide film, preparation method and application thereof TAIMIDE TECHNOLOGY INC 2013-10-30 CN claimed
US-5917034-A Antithrombotic n-amidinopiperidine and benzamidine derivatives PFIZER INC. (US) 1999-06-29 US claimed
EP-0858458-A1 ANTITHROMBOTIC N-AMIDINOPIPERIDINE AND BENZAMIDINE DERIVATIVES Pfizer Limited (GB) 1998-08-19 EP claimed
WO-1997016444-A1 ANTITHROMBOTIC N-AMIDINOPIPERIDINE AND BENZAMIDINE DERIVATIVES PFIZER LIMITED (GB) 1997-05-09 WO claimed
EP-3512852-B1 TRAF 6 INHIBITORS HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2024-06-26 EP disclosed
US-11931412-B2 JAK1 inhibitors and uses thereof WASHINGTON UNIVERSITY (US) 2024-03-19 US disclosed
CN-109715631-B TRAF6 inhibitors 德国亥姆霍兹慕尼黑中心健康与环境研究中心(有限公司) 2022-02-18 CN disclosed
US-11185548-B2 Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases HELMHOLTZ ZENTRUM MUNCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2021-11-30 US disclosed
US-20210338812-A1 JAK1 INHIBITORS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2021-11-04 US disclosed
US-11001591-B2 TRAF 6 inhibitors HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2021-05-11 US disclosed
US-10973913-B2 JAK inhibitors and uses thereof WASHINGTON UNIVERSITY (US) 2021-04-13 US disclosed
US-4622417-A DIETETICS GENERAL FOODS CORPORATION (US) 1986-11-11 US disclosed
EP-0199258-A2 L-Aminodicarboxylic acid amides and an edible composition containing same GENERAL FOODS CORPORATION (US) 1986-10-29 EP disclosed
US-4619782-A L-aminodicarboxylic acid gem-diamines GENERAL FOODS CORPORATION (US) 1986-10-28 US disclosed
EP-0186173-A2 L-Aminodicarboxylic-(0-cycloalkyl)-L-aminocarboxylate alkyl esters, an edible composition containing same as sweeteners and a method for sweetening an edible composition GENERAL FOODS CORPORATION (US) 1986-07-02 EP disclosed
US-4572799-A L-Aminodicarboxylic acid amides GENERAL FOODS CORPORATION (US) 1986-02-25 US disclosed
EP-0029657-A2 Pesticidal tetrazines, their use and compositions, processes for their preparation and preparation intermediates FBC LIMITED (GB) 1981-06-03 EP disclosed
US-4026910-A Oxidation process using nickel peroxide oxidizing agents HOFFMANN-LA ROCHE INC. (US) 1977-05-31 US disclosed
US-3994936-A Catalytic rearrangement HOFFMANN-LA ROCHE INC. (US) 1976-11-30 US disclosed